Allergan CEO: Turing price raise 'one egregious situation'

6:15 PM ET Mon, 21 Sept 2015

Mad Money host Jim Cramer speaks to the CEO of Allergan on the impact of Hillary Clinton's tweet about the drug pipeline, pricing, and Clinton's potential impact on the industry.